Introduction Conflicting results exist regarding whether preoperative transthoracic biopsy
increases the risk of pleural recurrence in early lung cancer. We conducted a systematic …

Objective Comorbidity is associated with adverse outcomes for all lung cancer patients, but
its burden is less understood in the context of screening. This review synthesises the …

Background: Lung cancer screening (LCS) using low-dose computed tomography (LDCT)
reduces lung cancer mortality but can lead to downstream procedures, complications, and …

Lung cancer is the most lethal malignant neoplasm worldwide, with an annual estimated
rate of 1.8 million deaths. Computed tomography has been widely used to diagnose and …

Background Flexible bronchoscopy is commonly used to examine patients suspected to
have lung cancer. Bronchial brushing is one of the cytological technologies for lung …

Objective Consequences of lung cancer screening (LCS) with low-dose chest CT in clinical
settings, including procedures, costs, and complications, are incompletely understood. We …

Background The harm associated with imaging abnormalities related to lung cancer
screening (LCS) is not well documented, especially outside the clinical trial and academic …

The purpose of this article is to review options for more rapid diagnosis of lung cancer at an
earlier stage, thereby improving survival. These options include screening, allowing general …

Abstract Objective Evaluate (1) frequency, type, and lung cancer stage in a clinical lung
cancer screening (LCS) population, and (2) association between patient characteristics and …

Background Definitive diagnosis of peripheral pulmonary lesions (PPLs) depends on the
histological analysis of the pleural biopsy sample. Ultrasound (US)-guided sampling is now …